SYAHRANI, R. A., LOUISA, M. and WANANDI, S. I. (2019) “SENSITIVITY OF BREAST CANCER STEM CELLS (CD24-/CD44+) TO DOXORUBICIN IS ASSOCIATED WITH OXIDATIVE STRESS STATUS”, International Journal of Applied Pharmaceutics, 11(6), pp. 91-96. doi: 10.22159/ijap.2019.v11s6.33555.